Key animal models for the identification and validation of drug targets

Drug Discovery Today

Volumn 6, Issue SUPPL.2, 2001, Pages

  Nef, Patrick ^a  

^a Preclinical Research   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 10844226726     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1359-6446(01)00165-9     Document Type: Review

References (45)

1. Drews, I.I. (2000) Drug discovery today - and tomorrow. Drug Discov. Today 5, 2-4
2. Blattner, F.R. et al. (1997) The complete genome sequence of Escherichia cell K-12. Science 277, 1453-1474
3. Josephy P.D. et al. (1997) Recent advances in the construction of bacterial genotoxicity assays. Mutat. Res. 386, 1-23
4. Saunders, N.J. and Moxon, E.R. (1998) Implications of sequencing bacterial genomes for pathogenesis and vaccine development. Curr. Opin. Biotechnol. 9, 618-623
5. Keasling, J.D. (1999) Gene-expression tools for the metabolic engineering of bacteria. Trends Biotechnol. 17, 452-460
6. Link, A.J. et al. (1997) Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: application to open reading frame characterization. J. Bacteriol. 179, 6228-6237
7. Hu, J.C. et al. (2000) Escherichia coli one- and two-hybrid systems for the analysis and identification of protein-protein interactions. Methods 20, 80-94
8. Saier, M.H., Jr (1996) Phylogenetic approaches to the identification and characterization of protein families and superfamilies. Microb. Comp. Genomics 1, 129-150
9. Tang, C.M. et al. (1998) Microbial genome sequencing and pathogenesis. Curr. Opin. Microbiol. 1, 12-16
10. Harfe, B.D. and Jinks-Robertson, S. (2000) DNA mismatch repair and genetic instability. Annu. Rev. Genet. 34, 359-399
11. Dujon, B. (1996) The yeast genome project: what did we learn? Trends Genet. 12, 263-270
12. Goffeau, A. et al. (1996) Life with 6000 genes. Science 274, 546, 563-567
13. Bassett, D.E., Jr. et al. (1996) Yeast genes and human disease. Nature 379, 589-590
14. Wodicka, L. et al. (1997) Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat. Biotechnol. 15, 1359-1367
15. Ross-Macdonald, P. et al. (1999) Large-scale analysis of the yeast genome by transposon tagging and gene disruption. Nature 402, 413-418
16. Schwikowski, B. et al. (2000) A network of protein-protein interactions in yeast. Nat. Biotechnol. 18, 1257-1261
17. Fields, S. and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340, 245-246
18. Munder, T. and Hinnen, A. (1999) Yeast cells as tools for target-oriented screening. Appl. Microbiol. Biotechnol. 52, 311-320
19. Fritz, E. et al. (2000) The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells. Mol. Biol. Cell 11, 2605-2616
20. Szczypka, M.S. et al. (1994) A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein. J. Biol. Chem. 269, 22853-22857
21. Brenner, S. (1974) The genetics of Caenorhabditis elegans. Genetics 77, 71-94
22. White, J.G. et al. (1988) The nematode Caenorhabditis elegans (Wood, WB., ed.), Cold Spring Harbor Laboratory
23. The C. elegans Sequencing Consortium (1998) Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282, 2012-2018 [published errata appeared in Science (1999) 283, 35; Science (1999) 283, 2103; and Science (1999) 285, 1493]
24. Chervitz, S.A. et al. (1998) Comparison of the complete protein sets of worm and yeast: orthology and divergence. Science 282, 2022-2028
25. Bargmann, C.I. (1998) Neurobiology of the Caenorhabditis elegans genome. Science 282, 2028-2033
26. Metzstein, M.M. et al. (1998) Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet. 14, 410-416
27. Ketting, R.F. and Plasterk, R.H. (2000) A genetic link between co-suppression and RNA interference in C. elegans. Nature 404, 296-298
28. Chalfie, M. et al. (1994) Green fluorescent protein as a marker for gene expression. Science 263, 802-805
29. Hodgkin, J. and Herman, R.K. (1998) Changing styles in C. elegans genetics. Trends Genet. 14, 352-357
30. Kim, S.K. (2001) Functional genomics: the worm scores a knockout. Curr. Biol. 11, R85-R87
31. Culetto, E. and Sattelle, D.B. (2000) A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes. Hum. Mol. Genet. 9, 869-877
32. Wittenburg, N. et al. (2000) Presenilin is required for proper morphology and function of neurons in C. elegans. Nature 406, 306-309
33. Adams, M.D. et al. (2000) The genome sequence of Drosophila melanogaster. Science 287, 2185-2195
34. Rong, Y.S. and Golic, K.G. (2000) Gene targeting by homologous recombination in Drosophila. Science 288, 2013-2018
35. Kazemi-Esfarjani, P. and Benzer, S. (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science 287, 1837-1840
36. Muller, U. (1999) Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis. Mech. Dev. 82, 3-21
37. Moreadith, R.W. and Radford, N.B. (1997) Gene targeting in embryonic stem cells: the new physiology and metabolism. J. Mol. Med. 75, 208-216
38. Takeda, J. et al. (2000) Conditional gene targeting and its application in the skin. J. Dermatol. Sci. 23, 147-154
39. Hrabe de Angelis, M. and Balling, R. (1998) Large scale ENU screens in the mouse: genetics meets genomics. Mutat. Res. 400, 25-32
40. Blake, J.A. et al. (2000) The Mouse Genome Database (MGD): expanding genetic and genomic resources for the laboratory mouse. Nucleic Acids Res. 28, 108-111
41. Owen, M.J. and Craddock, N. (1996) Modern molecular genetic approaches to complex traits: implications for psychiatric disorders. Mol. Psychiatry 1, 21-26
42. International Human Genome Sequencing Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921
43. Rudert, F. (2000) Genomics and proteomics tools for the clinic. Curr. Opin. Mol. Ther. 2, 633-642
44. Rudin, M. et al. (1999) In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives. NMR Biomed. 12, 69-97
45. Atwood, L.D. et al. (2001) Genome-wide linkage analysis of blood pressure in Mexican Americans. Genet. Epidemiol. 20, 373-382